{"id":26743,"date":"2023-01-30T13:54:12","date_gmt":"2023-01-30T13:54:12","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/ch-fr\/?page_id=26743"},"modified":"2025-12-29T09:04:48","modified_gmt":"2025-12-29T09:04:48","slug":"charles-morris","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris","title":{"rendered":"CHARLES MORRIS"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Charles Morris<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Charles Morris est Directeur du d\u00e9veloppement corporate et a rejoint Neuraxpharm en janvier 2022. Charles est un professionnel chevronn\u00e9 des fusions et acquisitions (F&A) avec 20 ans d\u2019exp\u00e9rience en banque d\u2019investissement et en F&A d\u2019entreprises dans l\u2019industrie pharmaceutique, dans plusieurs r\u00e9gions, dont les \u00c9tats-Unis, l\u2019Allemagne et l\u2019Espagne.<\/p>

Avant de rejoindre Neuraxpharm, Charles a \u00e9t\u00e9 Responsable mondial des F&A et du d\u00e9veloppement corporate chez Almirall (2019\u20132021). Auparavant, il avait occup\u00e9 le poste de Vice-Pr\u00e9sident, responsable des F&A, de la m\u00e9decine g\u00e9n\u00e9rale pharmaceutique et de la sant\u00e9 animale chez Bayer AG (2010\u20132019). Plus t\u00f4t dans sa carri\u00e8re, Charles a travaill\u00e9 dans le domaine de la banque d\u2019investissement et de la recherche sur les actions pour Bank of America, Merrill Lynch et Molecular Securities \u00e0 New York.<\/p>

Charles est titulaire d\u2019un MBA de la Columbia Business School (USA) et d\u2019une licence en \u00e9conomie et en sciences politiques de l\u2019universit\u00e9 Emory (USA).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm Charles Morris Charles Morris est Directeur du d\u00e9veloppement corporate et a rejoint Neuraxpharm en janvier 2022. Charles est un professionnel chevronn\u00e9 des fusions et acquisitions (F&A) avec 20 ans d\u2019exp\u00e9rience en banque d\u2019investissement et en F&A d\u2019entreprises dans l\u2019industrie pharmaceutique, dans plusieurs r\u00e9gions, dont les \u00c9tats-Unis, l\u2019Allemagne et l\u2019Espagne. Avant de rejoindre Neuraxpharm, […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-26743","page","type-page","status-publish","hentry"],"yoast_head":"\nCHARLES MORRIS - Neuraxpharm Switzerland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CHARLES MORRIS\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm Charles Morris Charles Morris est Directeur du d\u00e9veloppement corporate et a rejoint Neuraxpharm en janvier 2022. Charles est un professionnel chevronn\u00e9 des fusions et acquisitions (F&A) avec 20 ans d\u2019exp\u00e9rience en banque d\u2019investissement et en F&A d\u2019entreprises dans l\u2019industrie pharmaceutique, dans plusieurs r\u00e9gions, dont les \u00c9tats-Unis, l\u2019Allemagne et l\u2019Espagne. Avant de rejoindre Neuraxpharm, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Switzerland\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-29T09:04:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/charles-morris.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris\",\"name\":\"CHARLES MORRIS - Neuraxpharm Switzerland\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/charles-morris.jpg\",\"datePublished\":\"2023-01-30T13:54:12+00:00\",\"dateModified\":\"2025-12-29T09:04:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093942\/charles-morris.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093942\/charles-morris.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00c0 propos de nous\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 Ex\u00e9cutif\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CHARLES MORRIS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/\",\"name\":\"Neuraxpharm Switzerland\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CHARLES MORRIS - Neuraxpharm Switzerland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris","og_locale":"fr_FR","og_type":"article","og_title":"CHARLES MORRIS","og_description":"https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm Charles Morris Charles Morris est Directeur du d\u00e9veloppement corporate et a rejoint Neuraxpharm en janvier 2022. Charles est un professionnel chevronn\u00e9 des fusions et acquisitions (F&A) avec 20 ans d\u2019exp\u00e9rience en banque d\u2019investissement et en F&A d\u2019entreprises dans l\u2019industrie pharmaceutique, dans plusieurs r\u00e9gions, dont les \u00c9tats-Unis, l\u2019Allemagne et l\u2019Espagne. Avant de rejoindre Neuraxpharm, […]","og_url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris","og_site_name":"Neuraxpharm Switzerland","article_modified_time":"2025-12-29T09:04:48+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/charles-morris.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris","name":"CHARLES MORRIS - Neuraxpharm Switzerland","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/charles-morris.jpg","datePublished":"2023-01-30T13:54:12+00:00","dateModified":"2025-12-29T09:04:48+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093942\/charles-morris.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093942\/charles-morris.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/charles-morris#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00c0 propos de nous","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 Ex\u00e9cutif","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif"},{"@type":"ListItem","position":3,"name":"CHARLES MORRIS"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/","name":"Neuraxpharm Switzerland","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/26743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=26743"}],"version-history":[{"count":13,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/26743\/revisions"}],"predecessor-version":[{"id":27348,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/26743\/revisions\/27348"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=26743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}